Male-specific transplantation antigen expression by XY teratocarcinomas PCC7 and 7'

Immunogenetics
|January 1, 1984
PubMed

Insights

XY teratocarcinomas (PCC7 and 7') express male-specific antigens, leading to tumor rejection in female mice but not male mice. Loss of the Y chromosome in a PCC7 variant eliminated this antigen expression.

Area of Science:

  • Immunology
  • Developmental Biology
  • Cancer Research

Background:

  • Teratocarcinomas are tumors with diverse cell types.
  • XY teratocarcinomas can express male-specific antigens.
  • H-Y antigen plays a role in immune responses.

Purpose of the Study:

  • To demonstrate male-specific antigen expression in XY teratocarcinomas.
  • To investigate the genetic basis of male-specific antigen expression.
  • To explore the potential for selecting antigen-loss variants.

Main Methods:

  • Tumor challenge experiments in male and female mice.
  • Indirect immunization assays using H-Y antigen.
  • Karyotype and DNA analysis of teratocarcinoma variants.

Main Results:

  • PCC7 and 7' teratocarcinomas showed rejection in female mice, indicating male-specific antigen expression.
  • A PCC7 variant lacking male-specific antigen expression was identified.
  • Loss of the Y chromosome correlated with the absence of male-specific antigen expression.

Conclusions:

  • XY teratocarcinomas express male-specific antigens.
  • The Y chromosome is essential for male-specific antigen expression in these cells.
  • The identification of antigen-loss variants facilitates further research, including mutagenesis studies.

Related Concept Videos